Trials / Unknown
UnknownNCT04784468
DNA Damage and Oxidative Stress in Hospitalized COVID-19 Patients
DNA Damage and Oxidative Stress in Hospitalized COVID-19 Patients Compared to Healthy Controls: A Case-control Study
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 135 (estimated)
- Sponsor
- University of Vienna · Academic / Other
- Sex
- All
- Age
- 40 Years
- Healthy volunteers
- Accepted
Summary
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is responsible for the coronavirus disease 2019 (COVID-19) pandemic challenging health systems worldwide. While there is a clear correlation between oxidative stress markers and the severity of many viral diseases such as hepatitis C, for SARS-CoV clinical data is limited. The investigators aim at 1.) investigating DNA damage, oxidative stress, inflammation, and aging markers in COVID-19 patients and compare them with age and gender matched healthy controls and patients with influenza; and 2.) investigating all aforementioned parameters during "cytokine storm" via repeated blood sampling.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | No intervention | Case-control design, one single investigation |
Timeline
- Start date
- 2020-11-19
- Primary completion
- 2021-03-31
- Completion
- 2021-09-30
- First posted
- 2021-03-05
- Last updated
- 2021-03-09
Locations
1 site across 1 country: Austria
Source: ClinicalTrials.gov record NCT04784468. Inclusion in this directory is not an endorsement.